Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic Myeloma GM-CSF Vaccine

GM-CSF vaccine · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Myeloma GM-CSF Vaccine, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission [Phase 2]

See pricing